In the liver, NRG4 treatment had no impact on hepatic steatosis in LD mice, as assessed by liver weight, triglyceride content, and expression of genes involved in lipogenesis and fatty acid oxidation. The gene discussed is NRG4; the disease is Hepatic steatosis.